Tata Chemicals shares bounced back 14% from their intraday low of ₹690.35 to trade 2% higher at ₹750.55 on Wednesday, demonstrating strong investor confidence despite the initial volatility. The stock has zoomed 29% in the past two trading days following the Reserve Bank of India's rejection of Tata Sons' application to surrender its non-banking finance company (NBFC) licence. According to Business Standard, average trading volumes jumped multiple-fold, with a combined 223.29 lakh equity shares representing 31.72 times the two-week average daily volume of 7.04 lakh shares having changed hands on the NSE by 14:14 IST. The stock was quoting 2% higher at ₹750.55 compared to a 0.53% rise in the BSE Sensex at 11:14 AM, indicating strong relative performance. As per Upstox Securities, the stock rose for a second straight session, surging as much as 7.22% to an intraday high of ₹788 on top of yesterday's 20% gain.
Tata Chemicals shares surged 20% to ₹734.50, hitting the upper circuit on the NSE, marking their best single day gain since 2009. The rally was triggered by the company's announcement that its arm Tata Chemicals North America (TCNA) was declared the successful bidder in the Chapter 11 bankruptcy proceedings of Searles Valley Minerals Inc. (SVM), USA. According to the latest exchange filing, TCNA successfully completed the acquisition of customer contracts representing over 5,00,000 metric tonnes to be serviced over a two-year period, with the deal completed on September 11, 2026. As of 10:52 am, Tata Chemicals shares were locked in the 20% upper circuit with pending buy orders of 18,51,315 shares on the National Stock Exchange while there were no sellers on the exchange.
Despite the listing prospects, Tata Chemicals faces significant earnings pressure from weak global soda ash prices and rising costs. According to Bloomberg data, the average value of soda ash FOB China physical spot index has declined 10% in the ongoing September quarter (Q2FY27) from the Q1FY27 average. This global oversupply, driven by elevated Chinese utilisation rates, record inventory levels of about 1.7 million tonnes, and strong exports, has delayed demand-supply rebalancing. JM Financial Institutional Securities noted that pricing is expected to remain weak due to persistent global oversupply, with continued tensions in West Asia raising production costs. The company's Q1FY27 financials reflected these challenging conditions, with Ebitda declining 14% year-on-year to ₹555 crore despite consolidated revenue growing 14% to ₹4,255 crore. Motilal Oswal subsequently cut its FY27 earnings-per-share estimates by 19% following the weak quarterly results.
Deven Choksey of DRChoksey Finserv expects Tata Sons to eventually list and identifies Tata Chemicals as the top beneficiary of such a listing. According to CNBC TV18, Choksey explained that Shapoorji Pallonji Group holds close to 19% of Tata Sons and needs roughly ₹25,000 crore over the next one and a half to two years. Simultaneously, Air India requires about ₹24,000-25,000 crore in funding, Tata Electronics has a program worth ₹90,000 crore, and the group's digital businesses need another ₹28,000-29,000 crore. With Tata Consultancy Services (TCS) dividends of ₹28,000-29,000 crore not enough to cover all funding needs, Choksey said a Tata Sons listing becomes the most workable source of capital. He noted that Tata Chemicals' stake in Tata Sons is worth more than the company's entire current market value, making it the prime beneficiary of any listing proceeds.
The company has reorganized its businesses in Q1 to reduce exposure to cyclical businesses and redirect focus towards consumer and farm segments. Under the new structure, consumer-facing businesses such as salt and sodium bicarbonate have been classified as living essentials; soda ash and other industrial chemicals as industrial essentials; and agrochemicals and seeds as farm essentials. The industrial essentials segment, which contributes more than half of total revenue, saw revenue grow 13% in Q1, though Ebit swung to a loss of ₹70 crore from a profit of ₹131 crore a year earlier. Tata Chemicals' net debt at June-end stood at ₹5,692 crore, down sequentially from ₹5,961 crore at March-end, following asset monetization of ₹300 crore in Q1FY27. The company is evaluating further monetization in the second half of the fiscal.
Tata Chemicals shares declined almost 10% on Friday amid a boardroom disagreement over the public listing of Tata Sons, highlighting the ongoing uncertainty around the listing timeline. Despite the recent volatility, the stock has gained around 15% since the RBI's September 11 decision, providing some relief after losing about 20% in 2026. Motilal Oswal and JM Financial have set sum-of-the-parts-based target prices of ₹700 and ₹730 respectively, with the stock currently trading at ₹714. A recovery in soda ash prices will be key to meaningful earnings improvement in the near term, as management expects FY27 capital expenditure to be around ₹1,200 crore annually. The company's current market cap of ₹18,722 crore offers substantial value unlocking potential, though analysts remain cautious about the structural outlook for soda ash amid persistent global oversupply.
